On average, Mochi Health members lose 36 pounds in their first year, and most sustain their weight loss much longer than they ...
A recent study shows this one-time procedure is a more cost-effective option than the increasingly popular GLP-1 medication ...
Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...
Reuters spoke to three-dozen people inside the industry including retailers, drugmakers, telehealth providers and investors to show how the weight-loss sector is shifting to better meet consumers ...
Curious to know which obesity stories grabbed the attention of readers this year? Medscape Medical News develops a list of ...
As a 34-year-old based in Jakarta, Rosa “Ocha” Wardani is all too familiar with how the local society treats someone referred ...
For many people, the new year is the perfect time to get back on track when it comes to weight. However, figuring out how to ...
Prime Minister Christopher Luxon, centre, with (clockwise from top right), former prime ministers Jacinda Ardern, Chris ...
Healthcare in 2025 saw rapid innovation, rising costs, ACA subsidy expiration, AI adoption, consolidation, and affordability ...
Discover why Nigeria's informal workers, making up 90% of the workforce, face financial ruin without insurance. Learn about ...
Grains are building block of the Mediterranean diet, which can lead to weight loss. A 2017 study of 50 adults in the journal ...
The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback